Normal view MARC view ISBD view

Regulating innovation with uncertain quality: information, risk, and access in medical devices

By: Grennan, Matthew, and Town, Robert J.
Material type: materialTypeLabelBookPublisher: American Economic Review Description: 110(1), Jan 2020. p.120-61.Subject(s): Consumer protection - United States, Market Structure, Pricing In: American Economic ReviewSummary: We study the impact of regulating product entry and quality information requirements on an oligopoly equilibrium and consumer welfare. Product testing can reduce consumer uncertainty, but also increase entry costs and delay entry. Using variation between EU and US medical device regulations, we document patterns consistent with valuable learning from more stringent US requirements. To derive welfare implications, we pair the data with a model of supply, demand, and testing regulation. US policy is indistinguishable from the policy that maximizes total surplus in our estimated model, while the European Union could benefit from more testing. "Post-market surveillance" could further increase surplus.
Tags from this library: No tags from this library for this title. Log in to add tags.
    average rating: 0.0 (0 votes)
Item type Current location Call number Vol info Status Date due Barcode
Articles Articles Indian Institute of Public Administration
110(1), Jan 2020. p.120-61 Available AR122927

We study the impact of regulating product entry and quality information requirements on an oligopoly equilibrium and consumer welfare. Product testing can reduce consumer uncertainty, but also increase entry costs and delay entry. Using variation between EU and US medical device regulations, we document patterns consistent with valuable learning from more stringent US requirements. To derive welfare implications, we pair the data with a model of supply, demand, and testing regulation. US policy is indistinguishable from the policy that maximizes total surplus in our estimated model, while the European Union could benefit from more testing. "Post-market surveillance" could further increase surplus.

There are no comments for this item.

Log in to your account to post a comment.

Powered by Koha